Back HIV Policy & Advocacy IAS 2015: The Health Economics of HIV Treatment [VIDEO]

IAS 2015: The Health Economics of HIV Treatment [VIDEO]

alt

The world faces an opportunity to expand antiretroviral therapy to all who need it -- both to improve the health of individuals living with HIV and to prevent transmission of the virus -- and treatment would likely be cost-effective, experts agreed at a press briefing at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention last week in Vancouver.

[HIV Treatment and Prevention Media Briefing, IAS 2015, July 20, 2015]

Jens Lundgren from the University of Copenhagen, Myron Cohen from the University of North Carolina, Gottfried Hirnschall from the World Health Organization, IAS 2015 co-chair Julio Montaner from the British Columbia Centre for Excellence in HIV/AIDS, and Dazon Dixon Diallo from SisterLove in Atlanta participated in the discussion.

"It's either cost-effective or cost-saving to do early treatment," said Cohen. "This is kind of a no-brainer -- it's just a question of the political will to make the investment instead of buying another submarine."

7/28/15

Reference

8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Vancouver, July 19-22, 2015. Media Briefing. July 20, 2015.